Literature DB >> 454427

Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents.

K V Honn, J R Dunn, L R Morgan, M Bienkowski, L J Marnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 454427     DOI： 10.1016/0006-291x(79)92028-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  5 in total

1.  Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.

Authors:  S H Khan; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells.

Authors:  Y Kikuchi; T Kita; M Miyauchi; J Hirata; H Sasa; I Nagata; M Fukushima
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours--an experimental study in rats.

Authors:  S B Holmberg; P L Naredi; G O Lindnér; I H Karlberg; P L Daneryd; L M Karlsson; A Pettersson; U Stenram; L R Hafström
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

4.  Inhibition of tumor growth and metastasis by chronic intravenous infusion of prostaglandin E1.

Authors:  L M Ellis; E M Copeland; K I Bland; H S Sitren
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

5.  Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin.

Authors:  A Bennett; M A Carroll; P B Melhuish; I F Stamford
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.